Skip to main content
. 2020 May 5;9(5):1349. doi: 10.3390/jcm9051349

Table 3.

Changes in quality of life (QoL) for MS patients before and after a new treatment.

Dimensions Pre-Treatment (Mean ± SD) Post-Treatment (Mean ± SD) Difference between Scores Post- and Pre-Treatment (Mean ± SD) p-Value
Moving 0.64 (±0.25) 0.68 (±0.27) 0.03 (±0.09) 0.102
Seeing 0.73 (±0.21) 0.78 (±0.19) 0.05 (±0.10) 0.039
Hearing 0.88 (±0.17) 0.87 (±0.19) −0.01 (±0.06) 0.317
Breathing 0.69 (±0.3) 0.77 (±0.25) 0.08 (±0.12) 0.007
Sleeping 0.58 (±0.21) 0.73 (±0.22) 0.15 (±0.13) <0.001
Eating 0.65 (±0.26) 0.68 (±0.26) 0.02 (±0.08) 0.180
Speech 0.73 (±0.2) 0.77 (±0.22) 0.03 (±0.10) 0.083
Excretion 0.49 (±0.28) 0.53 (±0.27) 0.04 (±0.10) 0.059
Usual Activities 0.51 (±0.31) 0.56 (±0.3) 0.05 (±0.10) 0.027
Mental Function 0.69 (±0.25) 0.71 (±0.25) 0.02 (±0.09) 0.180
Discomfort 0.65 (±0.24) 0.71 (±0.26) 0.06 (±0.15) 0.165
Depression 0.62 (±0.2) 0.69 (±0.21) 0.07 (±0.15) 0.016
Distress 0.71 (±0.21) 0.76 (±0.22) 0.05 (±0.13) 0.046
Vitality 0.58 (±0.24) 0.64 (±0.19) 0.06 (±0.11) 0.018
Sexual Activity 0.77 (±0.22) 0.78 (±0.23) 0.01 (±0.06) 0.317
Total 0.66 (±0.18) 0.71 (±0.16) 0.05 (±0.03) <0.001